LENZ Therapeutics, Inc

Quick facts

Phase 3 pipeline

• Aceclidine+Brimonidine combination ophthalmic solution · Ophthalmology
  This combination stimulates muscarinic receptors (via aceclidine) and alpha-2 adrenergic receptors (via brimonidine) to increase aqueous humor outflow and reduce intraocular pressure in the eye.
• Aceclidine ophthalmic solution · Ophthalmology
  Aceclidine is a cholinergic agonist that stimulates muscarinic receptors in the eye to increase accommodation and improve near vision.

Phase 2 pipeline

• PRX-100

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• LENZ Therapeutics, Inc portfolio CI brief
• LENZ Therapeutics, Inc pipeline updates RSS